BODIPY vs Oil Red O for Lipid Droplets
The Comparison
| Property | BODIPY 493/503 | Oil Red O |
|---|---|---|
| Chemistry | Neutral lipid-binding fluorophore | Lysochrome dye, solubility-based |
| Live cells | Yes | No |
| Fixed cells | Yes, with compatible fixative | Yes; requires fixation |
| Quantification | Fluorescence intensity or object-based | Colorimetric absorbance or image density |
| Multiplexing | With antibodies, if spectrally separated | Poor; strong red absorbance |
| Droplet morphology | Excellent | Good |
| Solvent compatibility | Avoids non-polar mountants that dissolve droplets | Some mountants extract the dye |
| Dynamic range | Wide, with photobleaching | Narrower; saturation at high lipid |
Important distinction. BODIPY 493/503 binds neutral lipids generally — triglycerides and cholesteryl esters — with a preference that varies by species and by the local environment. Oil Red O is more strongly associated with triglycerides but also stains cholesteryl esters and some other lipids. Neither distinguishes triglyceride from cholesteryl ester, and neither reports phospholipid.
Part 1 — Practical Conditions
BODIPY.
- • Working concentration 0.1–1 µg/mL, from a DMSO stock; higher concentrations produce non-specific membrane staining.
- • Live imaging: 10–15 minutes at 37 °C, then wash; minimal illumination to limit photobleaching.
- • Fixed: 4% PFA 10–15 minutes; avoid methanol, which extracts neutral lipid.
- • Spectral: 493/503 excitation and emission for the standard probe; a 558/568 variant exists for multiplexing with green fluorophores.
- • Quantification: per-droplet objects rather than total intensity, where the question concerns number or size.
Oil Red O.
- • Stock in isopropanol, diluted into water or buffer immediately before use; precipitation is the main artefact.
- • Fix with 4% PFA or formalin; wash thoroughly before staining.
- • Staining 10–20 minutes, then wash and image in aqueous mountant.
- • Quantification: extract the dye in isopropanol and read absorbance, or quantify image density — extraction is more reproducible for well-based assays.
Part 2 — Artefacts
| Artefact | BODIPY | Oil Red O |
|---|---|---|
| Dye precipitation | Rare at working concentrations | Common; crystals mimic droplets |
| Non-specific membrane staining | At high concentration | Less so |
| Photobleaching | Significant; affects quantitation | Not applicable |
| Dye extraction by mountant | With non-polar mountants | With some aqueous mountants |
| Fixative dissolving droplets | Methanol, some detergents | Same |
| Saturation | High lipid loads | High lipid loads |
| Background from medium lipids | If not washed | If not washed |
Caveat on precipitated ORO. The crystals are intensely coloured and irregular, and they appear in the same size range as small droplets. Filtration of the working solution and a no-lipid control well are the standard checks; without them, a treated well with more precipitate looks like a well with more droplets.
Part 3 — Quantification That Supports a Claim
| Question | Appropriate measurement | Not appropriate |
|---|---|---|
| Is there more neutral lipid? | Total fluorescence per cell, normalised | Number of visible droplets in a field |
| Are there more droplets? | Object count per cell with a stated size threshold | Total intensity |
| Are droplets larger? | Per-object area distribution | Mean intensity |
| Is a treatment toxic? | Viability in the same wells | Droplet abundance |
| Is the coat protein changed? | PLIN2 immunofluorescence with droplet costaining | PLIN2 alone |
Readout note. Reporting "BODIPY intensity increased" answers the first question and is frequently described as if it answered the second or third. Since droplet number and size have different biology, a per-object analysis — even a simple histogram — is worth the extra analysis step.
Part 4 — When Neither Is Appropriate
- • Species identification. Neither stain resolves triglyceride versus cholesteryl ester; lipidomics is required.
- • Compartment assignment. Neither reports which membrane a lipid has entered.
- • Flux. Neither reports synthesis or turnover; a pulse-chase with labelled fatty acid is required.
- • Toxicity. Staining abundance is not injury; viability must be measured.
- • Cholesterol-specific questions. Filipin is the appropriate free-cholesterol stain; the neutral lipid dyes report the esterified pool poorly and non-specifically.
Part 5 — Common Failures
- • Precipitated ORO interpreted as droplets.
- • BODIPY intensity reported as droplet number.
- • Methanol fixation used with either stain.
- • Non-polar mountant used with BODIPY, extracting the lipid along with the dye.
- • Droplet counts without a stated size threshold.
- • No viability measurement, so accumulation is read as injury.
- • Staining after long serum exposure without washing, giving high background.
- • Imaging settings changed between conditions, invalidating intensity comparison.
Part 6 — Where This Article Connects
This is the first analytical article of the lipid cluster, and it exists because most lipotoxicity figures begin with a droplet stain. The droplet biology article covers what the stain is showing biologically; the triglyceride assay article covers the quantitative alternative; and the lipidomics-based articles cover species resolution, which no stain provides.
If you need droplet imaging with per-object quantification and viability in the same wells, we can scope the protocol with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Stain performance, linear range and background vary with cell type, fixative, mountant and imaging settings; the conditions here are starting points requiring local validation.
Neutral lipid staining does not identify lipid species, and it does not establish toxicity.
Scientific interpretation and experimental design
- • Two chemistries, one limitation. Neither resolves species.
- • ORO precipitates. Filter it and use a no-lipid control.
- • BODIPY bleaches. Fixed-time acquisition across conditions.
- • Avoid methanol. It extracts the object.
- • Object-based analysis for number and size.
- • Staining is not injury. Measure viability.
Selected references for further reading
- • Listenberger LL, Brown DA. Fluorescent detection of lipid droplets and associated proteins. Current Protocols in Cell Biology. 2007;Chapter 24:Unit 24.2.
- • Mehlem A, et al. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nature Protocols. 2013;8:1149–1154.
- • Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nature Reviews Molecular Cell Biology. 2019;20:137–155.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »